Milestone Pharmaceuticals files initial beneficial ownership statement for finance vice president Anthony J. Krick
MIST•Milestone Pharmaceuticals Vice President, Finance Anthony J. Krick disclosed employee share options covering 100,000 common shares at $1.32 in a Form 3.




